Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Core PCE Price Index Annual Change in the United States increased to 2.91 percent in August from 2.85 percent in July of 2025. This dataset includes a chart with historical data for the United States Core Pce Price Index Annual Change.
https://www.ycharts.com/termshttps://www.ycharts.com/terms
View monthly updates and historical trends for US Core PCE Price Index YoY. from United States. Source: Bureau of Economic Analysis. Track economic data w…
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Core PCE Price Index in the United States increased to 126.71 points in August from 126.42 points in July of 2025. This dataset provides - United States Core Pce Price Index - actual values, historical data, forecast, chart, statistics, economic calendar and news.
https://fred.stlouisfed.org/legal/#copyright-public-domainhttps://fred.stlouisfed.org/legal/#copyright-public-domain
Graph and download economic data for Personal Consumption Expenditures Excluding Food and Energy (Chain-Type Price Index) (PCEPILFE) from Jan 1959 to Aug 2025 about core, chained, energy, headline figure, PCE, consumption expenditures, consumption, personal, inflation, price index, indexes, price, and USA.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Core PCE Price Index MoM in the United States remained unchanged at 0.20 percent in August. This dataset includes a chart with historical data for the United States Core Pce Price Index MoM.
https://fred.stlouisfed.org/legal/#copyright-public-domainhttps://fred.stlouisfed.org/legal/#copyright-public-domain
Graph and download economic data for Personal Consumption Expenditures: Chain-type Price Index (PCEPI) from Jan 1959 to Aug 2025 about chained, headline figure, PCE, consumption expenditures, consumption, personal, inflation, price index, indexes, price, and USA.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Core consumer prices in the United States increased 3.10 percent in August of 2025 over the same month in the previous year. This dataset provides - United States Core Inflation Rate - actual values, historical data, forecast, chart, statistics, economic calendar and news.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
The Federal Reserve Bank of Cleveland provides daily “nowcasts” of inflation for two popular price indexes, the price index for personal consumption expenditures (PCE) and the Consumer Price Index (CPI). These nowcasts give a sense of where inflation is today. Released each business day.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Inflation Nowcasting Quarterly is a part of the Inflation Nowcasting indicator of the Federal Reserve Bank of Cleveland.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
PCE Price Index in the United States increased to 127.29 points in August from 126.95 points in July of 2025. This dataset provides the latest reported value for - United States Personal Consumption Expenditure Price Index - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IntroductionSome cases of percutaneous coronary intervention (PCI) for the anastomotic site between the Cabrol-type conduit and the left main coronary artery (LMCA) have been reported. Nevertheless, the combination of PCI with a detailed description of lesion appearance using virtual histology-intravascular ultrasound (VH-IVUS) has never been reported. In this study, we present a case of acute myocardial infarction that was successfully treated with intravascular ultrasound (IVUS)-guided PCI for focal stenosis at the anastomotic site, and the plaque composition was studied in detail.Case PresentationA 35-year-old Korean male with Behçet's disease was diagnosed with acute myocardial infarction. He had previously undergone three cardiothoracic surgeries including two aortic replacements, followed by modified Bentall operation with a Cabrol-type aortocoronary anastomosis. Coronary angiogram (CAG) showed focal critical stenosis at the anastomosis site between the conduit and the LMCA, and VH-IVUS showed fibrotic plaque with mainly fibrous tissue but without a confluent necrotic core. PCI was performed using a drug-eluting stent (4.5 × 12 mm, SynergyTM, Boston Scientific, Marlborough, MA, USA). Since a repeat CAG and IVUS post-surgery showed an under-expanded stent strut, post-dilation ballooning was additionally performed. Subsequently, the repeat IVUS revealed wellapposed and optimized deployment of the drug-eluting stent with full lesion coverage. Final CAG showed optimal angiographic results. After successful PCI, the patient's anginal symptoms improved dramatically, and he was successfully discharged from our hospital.ConclusionThis study presents an IVUS-guided PCI case for an anastomotic site between the conduit and the LMCA. It is the first to investigate the characteristics of this lesion through VH-IVUS, which demonstrated the presence of fibrous plaques at the anastomotic site. IVUS radiofrequency data allow for a detailed assessment of plaque composition and provide new insights into the histopathological nature of stenotic lesions at the anastomotic site, especially in patients with chronic inflammatory diseases like Behçet's disease.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Percutaneous coronary intervention with implantation of second-generation drug-eluting stents (DES) has emerged as a mainstay for the treatment of obstructive coronary artery disease given its beneficial impact on clinical outcomes in these patients. Everolimus-eluting stents (EES) are one of the most frequently implanted second-generation DES; their use for the treatment of a wide range of patients including those with complex coronary lesions is supported by compelling evidence. Although newer stent platforms such as biodegradable polymer DES may lower local vessel inflammation, their efficacy and safety have not yet surpassed that of Xience stents. This article summarizes the properties of the Xience family of EES and the evidence supporting their use across diverse patient demographics and coronary lesion morphologies. Plain language summary: Patients with coronary artery disease (CAD) often require treatment for symptoms caused by blockages in coronary arteries. In addition to medical therapy, available procedure options include either coronary artery bypass grafting, a major heart surgery or percutaneous coronary intervention (PCI) with stenting. PCI is a minimally invasive procedure where ametallic stent (ameshmade up of fine metallic network in a tube shape used to keep vessels open) is advanced over a wire through an artery to open the coronary artery blockage. Over the past few decades, improvements in procedure technique and stent material have made PCI a highly safe and efficacious procedure. A newer generation of stents, known as drug-eluting stents (DES), have been developed in which metallic struts are covered with a highly biocompatible polymer (a thin material coating over the metallic mesh) that releases drugs at the blockage site to prevent local cell growth in the vessel wall. Among the second-generation DES, Xience everolimus-eluting stents (EES) have shown better outcomes compared with earlier generations of stents. Another version of DES with biodegradable polymer coating is emerging but their advantage over EES remains uncertain. Currently, Xience EES are one of the most commonly used stents to treat CAD. This manuscript covers an in-depth review of clinical evidence on the performance of Xience stents in a diverse range patient populations.
Various cancer immunotherapies rely on the T cell recognition of peptide antigens presented on human leukocyte antigens (HLA). However, the identification and selection of naturally presented peptide targets for the development of personalized as well as off-the-shelf immunotherapy approaches remains challenging. Here, we introduce the open-access Peptides for Cancer Immunotherapy Database (PCI-DB, https://pci-db.org/), a comprehensive resource of immunopeptidome data originating from various malignant and benign primary tissues that provides the research community with a convenient tool to facilitate the identification of peptide targets for immunotherapy development. The PCI-DB includes > 6.6 million HLA class I and > 3.4 million HLA class II peptides from over 40 tissue types and cancer entities analyzed uniformly using high-sensitive nf-core bioinformatics pipelines and applying a global peptide false discovery rate (FDR) approach. First application of the database provided insights into the representation of cancer-testis antigens (CTA) across malignant and benign tissues and enabled the identification and characterization of the cross-tumor entity and entity-specific tumor-associated antigens as well as naturally presented neoepitopes from frequent cancer mutations. Further, we used the PCI-DB to design personalized peptide vaccines for two patients suffering from metastatic cancer. PCI-DB enabled the composition of both a multi-peptide vaccine comprising non-mutated, highly frequent tumor-associated antigens matching the immunopeptidome of the individual patient´s tumor and a neoepitope-based vaccine matching the mutational profile of the cancer patient. Both vaccine approaches induced potent and long-lasting T-cell responses, accompanied by long-term survival of these advanced cancer patients. In conclusion, the PCI-DB provides a highly versatile tool to broaden the understanding of cancer-related antigen presentation and, ultimately, supports the development of novel immunotherapies.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
IntroductionMost deaf babies are born to hearing families who do not yet have the skills to communicate effectively with their child. Adaptations to communication are important because the quality of parent-child interaction (PCI) predicts how a deaf child develops language. Teachers of Deaf children and Speech and Language Therapists support families with communication in the home. Currently, there are no assessments that appraise how a parent interacts with their deaf baby. Previous research has identified which parent behaviours and approaches are used in PCI assessments in research and practice. The current paper forms consensus on the core content and best practices of a new PCI tool for deaf children aged 0–3 years.MethodsAn international sample of expert academics and practitioners (n = 83) were recruited to take part in a two-round modified electronic Delphi study. Participants were presented with 69 statements focusing on (i) which parent behaviours were important in assessment (ii) the methods to be used in PCI assessment. Participants rated the extent to which they agreed or disagreed with each statement on a five-point Likert scale and gave comments to support their response. Consensus was defined as >80% of participants rating the statement as a (4) ‘highly important’ or a (5) ‘essential’. If consensus was not reached, participant comments were used to generate new statements which were rated in the second round. This project involved a patient and public involvement (PPI) group of hearing and deaf parents and professionals to design and guide the study.ResultsConsensus was achieved on 52 statements and ranged from 80–99%. A further six statements were additionally included. Within the 58 statements included, 36 were parent behaviours which centred on the parent’s observation of, and response to, their child’s behaviour and/or language. The remaining 22 statements focused on methods used in the assessment such as parents having their PCI filmed, parents having the opportunity to review the video and assess themselves alongside a professional, and parents being involved in subsequent goal setting.ConclusionsThis e-Delphi presented the parent behaviours and methods of assessment to be included in a new PCI tool for deaf children. Future co-production work and acceptability and feasibility testing are discussed.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Diluted-Average-Shares Time Series for Pci-Suntek Technology Co Ltd. Pci Technology Group Co.,Ltd. provides artificial intelligence technology and products in China. The company offers intelligent rail transportation solutions, including intelligent subway, station, security check, customer service, operation and maintenance, energy saving, Metro Depot, and emergency response; network command; urban rail cloud; digital transformation; transit network integration; and interconnection of existing lines. It also provides intelligent operations control platform, ISCS integrated management control system, ACC and NPS Ticketing clearing system, MLC and CS AFC system, CCTV comprehensive security, PIDS passenger information system, smart security inspection system, AI environmental control energy-saving system, and biometric recognition system. In addition, the company offers ticket checking, ticketing, customer service, platform screen, edge all-in-one, and intelligent video analysis equipment; and core module products, such as door module, coin, ticket card module, access and control module, PSD module, OPS/LCD player. Further, it provides vehicle management E-book AI customer service, traffic vision large model, non-motorized vehicle management, traffic multimodal, intelligent traffic analysis, traffic spatiotemporal prediction, and vehicle-pedestrian structure analysis storage-compute-check integrated equipment; and IoT perception products, including traffic flow detector, radar vision traffic flow detector, traffic millimeter wave radar, radar vision integrated machine, RF video integrated machine reader-writer, edge intelligent mini station holographic / non-motorized vehicle / incident /parking version, and traffic control machine. Additionally, the company offers smart city governance solutions comprising emergency management, safety production, and intelligent public security. The company was formerly known as PCI-Suntek Technology Co.,Ltd. Pci Technology Group CO.,LTD. was founded in 1986 and is headquartered in Guangzhou, China.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
BackgroundThis study compares the efficacy of coronary computed tomography angiography (CCTA) and near-infrared spectroscopy intravascular ultrasound (NIRS–IVUS) in patients with significant coronary stenosis for predicting periprocedural myocardial injury during percutaneous coronary intervention (PCI).MethodsWe prospectively enrolled 107 patients who underwent CCTA before PCI and performed NIRS–IVUS during PCI. Based on the maximal lipid core burden index for any 4-mm longitudinal segments (maxLCBI4mm) in the culprit lesion, we divided the patients into two groups: lipid-rich plaque (LRP) group (maxLCBI4mm ≥ 400; n = 48) and no-LRP group (maxLCBI4mm
MIT Licensehttps://opensource.org/licenses/MIT
License information was derived automatically
Protein-Protein, Genetic, and Chemical Interactions for Khoshnevis S (2014):Structural integrity of the PCI domain of eIF3a/TIF32 is required for mRNA recruitment to the 43S pre-initiation complexes. curated by BioGRID (https://thebiogrid.org); ABSTRACT: Transfer of genetic information from genes into proteins is mediated by messenger RNA (mRNA) that must be first recruited to ribosomal pre-initiation complexes (PICs) by a mechanism that is still poorly understood. Recent studies showed that besides eIF4F and poly(A)-binding protein, eIF3 also plays a critical role in this process, yet the molecular mechanism of its action is unknown. We showed previously that the PCI domain of the eIF3c/NIP1 subunit of yeast eIF3 is involved in RNA binding. To assess the role of the second PCI domain of eIF3 present in eIF3a/TIF32, we performed its mutational analysis and identified a 10-Ala-substitution (Box37) that severely reduces amounts of model mRNA in the 43-48S PICs in vivo as the major, if not the only, detectable defect. Crystal structure analysis of the a/TIF32-PCI domain at 2.65-A resolution showed that it is required for integrity of the eIF3 core and, similarly to the c/NIP1-PCI, is capable of RNA binding. The putative RNA-binding surface defined by positively charged areas contains two Box37 residues, R363 and K364. Their substitutions with alanines severely impair the mRNA recruitment step in vivo suggesting that a/TIF32-PCI represents one of the key domains ensuring stable and efficient mRNA delivery to the PICs.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Total-Long-Term-Assets Time Series for Pci-Suntek Technology Co Ltd. Pci Technology Group Co.,Ltd. provides artificial intelligence technology and products in China. The company offers intelligent rail transportation solutions, including intelligent subway, station, security check, customer service, operation and maintenance, energy saving, Metro Depot, and emergency response; network command; urban rail cloud; digital transformation; transit network integration; and interconnection of existing lines. It also provides intelligent operations control platform, ISCS integrated management control system, ACC and NPS Ticketing clearing system, MLC and CS AFC system, CCTV comprehensive security, PIDS passenger information system, smart security inspection system, AI environmental control energy-saving system, and biometric recognition system. In addition, the company offers ticket checking, ticketing, customer service, platform screen, edge all-in-one, and intelligent video analysis equipment; and core module products, such as door module, coin, ticket card module, access and control module, PSD module, OPS/LCD player. Further, it provides vehicle management E-book AI customer service, traffic vision large model, non-motorized vehicle management, traffic multimodal, intelligent traffic analysis, traffic spatiotemporal prediction, and vehicle-pedestrian structure analysis storage-compute-check integrated equipment; and IoT perception products, including traffic flow detector, radar vision traffic flow detector, traffic millimeter wave radar, radar vision integrated machine, RF video integrated machine reader-writer, edge intelligent mini station holographic / non-motorized vehicle / incident /parking version, and traffic control machine. Additionally, the company offers smart city governance solutions comprising emergency management, safety production, and intelligent public security. The company was formerly known as PCI-Suntek Technology Co.,Ltd. Pci Technology Group CO.,LTD. was founded in 1986 and is headquartered in Guangzhou, China.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Background and ObjectivesThe predictive value of plaque characteristics assessed by virtual histology-intravascular ultrasound (VH-IVUS) including fibrous tissue (FT), fibrofatty (FF), necrotic core (NC) and dense calcium (DC) in identifying distal embolization after percutaneous coronary intervention (PCI) is still controversial. We performed a systematic review and meta-analysis to summarize the association of pre-PCI plaque composition and post-PCI distal embolization in acute coronary syndrome patients.MethodsStudies were identified in PubMed, OVID, EMBASE, the Cochrane Library, the Current Controlled Trials Register, reviews, and reference lists of relevant articles. A meta-analysis using both fixed and random effects models with assessment of study heterogeneity and publication bias was performed.ResultsOf the 388 articles screened, 10 studies with a total of 872 subjects (199 with distal embolization and 673 with normal flow) met the eligibility of our study. Compared with normal flow groups, significant higher absolute volume of NC [weighted mean differences (WMD): 5.79 mm3, 95% CI: 3.02 to 8.55 mm3; p
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Consumer Price Index CPI in the United States increased to 323.98 points in August from 323.05 points in July of 2025. This dataset provides the latest reported value for - United States Consumer Price Index (CPI) - plus previous releases, historical high and low, short-term forecast and long-term prediction, economic calendar, survey consensus and news.
Attribution 4.0 (CC BY 4.0)https://creativecommons.org/licenses/by/4.0/
License information was derived automatically
Core PCE Price Index Annual Change in the United States increased to 2.91 percent in August from 2.85 percent in July of 2025. This dataset includes a chart with historical data for the United States Core Pce Price Index Annual Change.